CG Oncology CGON Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:ReceivablesNetCurrent.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's accounts receivable?
- CG Oncology (CGON) reported accounts receivable of $1.28M in Q1 2026.
- How has CG Oncology's accounts receivable changed year-over-year?
- CG Oncology's accounts receivable increased by 269.6% year-over-year, from $345K to $1.28M.
- What is the long-term trend for CG Oncology's accounts receivable?
- Over 2 years (2023 to 2025), CG Oncology's accounts receivable has grown at a 173.5% compound annual growth rate (CAGR), from $92K to $688K.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.